← Eichor
Condition: Cell Free Dna Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cell Free Dna

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Phase N/A · 71 location(s) · Royal Marsden NHS Foundation Trust · NCT04050345
HPV After chemoRadioTherapy
Phase N/A · 1 location(s) · General University Hospital, Prague · NCT07493928
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03791034
cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas
NA · 4 location(s) · Centre Jean Perrin · NCT07178847
Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Phase N/A · 1 location(s) · JaxBio Ltd · NCT06963307
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Phase N/A · 1 location(s) · Zhongda Hospital · NCT07573735
Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351488
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03117036
A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell
Phase N/A · 1 location(s) · Royal College of Surgeons, Ireland · NCT07503704
Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
Phase N/A · 1 location(s) · Baohui Han · NCT07399210
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06439810
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Dis
NA · 2 location(s) · M.D. Anderson Cancer Center · NCT05676450
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation
NA · 1 location(s) · University Health Network, Toronto · NCT04901884
Cell Free DNA in Mature B-cell Lymphoma
Phase N/A · 1 location(s) · Ruijin Hospital · NCT04088422
Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Wome
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07471373
Cell-free DNA in Acute Stroke
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT06928675
Post-operative Monitoring of Gastric Cancer
Phase N/A · 1 location(s) · Suzhou Huhu Health & Technology Inc. · NCT07026240
Prospective Study for the Development, Validation and Confirmation of a Multi-Cancer Early Detection Platform Through Wh
Phase N/A · 1 location(s) · Chang Gon Kim · NCT07598747
TCF-001 TRACK (Target Rare Cancer Knowledge) Study
NA · 1 location(s) · TargetCancer Foundation · NCT04504604
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
Phase N/A · 1 location(s) · Devyser Inc. · NCT06690099
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Phase N/A · 6 location(s) · Devyser Inc. · NCT07006831
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplant
Phase N/A · 2 location(s) · University of Turin, Italy · NCT06715046
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papil
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05307939
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Phase N/A · 14 location(s) · Sequenom, Inc. · NCT01429389
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
Phase N/A · 1 location(s) · Sequenom, Inc. · NCT02586389
Trifecta-Kidney cfDNA-MMDx Study
Phase N/A · 31 location(s) · University of Alberta · NCT04239703
Comprehensive Assessment of First Trimester Pregnancy Loss
Phase N/A · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07293819
PRostate Cancer Plasma Integrative Multi-modal Evaluation
Phase N/A · 4 location(s) · Santa Chiara Hospital · NCT06981377
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and
NA · 4 location(s) · Centre Jean Perrin · NCT05710679
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT04814407
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.